Latest Features

Type 2 Diabetes Advisor Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes

Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes

According to a 2016 study, the mean price of insulin increased nearly 3-fold between 2002 and 2013.

Type 2 Diabetes Advisor The Obesity Paradox in Diabetes: Conceptual and Clinical Approaches

The Obesity Paradox in Diabetes: Conceptual and Clinical Approaches

Overweight and obesity are established risk factors for the development of metabolic diseases, including diabetes, hypertension, dyslipidemia, and cardiovascular disease.

Pediatric Endocrinology Smoothing the Care Team Transition for Youth With Type 1 Diabetes

Smoothing the Care Team Transition for Youth With Type 1 Diabetes

The transition from pediatric to adult care for type 1 diabetes should be a gradual process, with a plan to make the change when the patient is ready, not at a pre-determined time.

Pediatric Endocrinology Idiopathic Short Stature: Expert Perspectives

Idiopathic Short Stature: Expert Perspectives

Guidelines from The Endocrine Society, updated in 2017, advocate a shared decision-making approach regarding growth hormone therapy and advise against routine treatment for all children with idiopathic short stature.

Diabetes Detecting and Treating Depression in Diabetes

Detecting and Treating Depression in Diabetes

Comorbid depression, when not well controlled, can affect one's ability to self-manage diabetes. There can be loss of interest in making proper lifestyle choices, monitoring glucose levels, and taking one's medicines.

Type 2 Diabetes Advisor Type 2 Diabetes and Alzheimer Disease: What's the Connection?

Type 2 Diabetes and Alzheimer Disease: What's the Connection?

Findings suggest that insulin resistance and deficiency may increase the risk of Alzheimer disease via their influence on brain function.

Thyroid Subclinical Hypothyroidism: Controversies in Testing and Treatment

Subclinical Hypothyroidism: Controversies in Testing and Treatment

Divergent recommendations in guidelines from the USPSTF and the ATA/AACE contribute to the controversy surrounding whether to test and treat for subclinical hypothyroidism.

General Endocrinology Hormonal Contraceptives and Migraine: Is It Time to Revisit Stroke Risk?

Hormonal Contraceptives and Migraine: Is It Time to Revisit Stroke Risk?

Current oral contraceptive products contain lower doses of estrogen than those used in the past, prompting reconsideration of risks and benefits.

Type 2 Diabetes Advisor Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment

Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment

Environmental causes of T2D and other metabolic disorders are often overlooked; a new body of evidence, however, is changing the clinical thinking about mitigating these effects on those at high risk of T2D.

Obesity Examining the Obesity Paradox in Patients With Rheumatoid Arthritis

Examining the Obesity Paradox in Patients With Rheumatoid Arthritis

Obesity has a substantial effect on general health parameters, but its role in rheumatoid arthritis is much more complex.

Type 2 Diabetes Advisor Managing Diabetes Risk in Polycystic Ovary Syndrome

Managing Diabetes Risk in Polycystic Ovary Syndrome

Insulin resistance contributes to the increased risk of type 2 diabetes in individuals with polycystic ovary syndrome.

Type 1 Diabetes Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective

Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective

Although metformin has been studied in randomized trials as adjunctive therapy to insulin in individuals with type 1 diabetes, further investigation in the form of outcomes trials is necessary to assess risks vs benefits.

Practice Management A Few Bad Apples: Managing Malpractice Claims

A Few Bad Apples: Managing Malpractice Claims

Ranking or otherwise gauging physician quality isn't just a way to assign bragging rights — performance metrics can be used to set reimbursement levels, tailor insurance, and identify physicians who are falling behind.

Type 2 Diabetes Advisor SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights

SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights

Dr Bush discusses the combination of SGLT2 inhibitors and GLP-1 receptor agonist for the treatment of type 2 diabetes.

Type 2 Diabetes Clinician Perspective: Examining the Link Between Antipsychotics and Diabetes

Clinician Perspective: Examining the Link Between Antipsychotics and Diabetes

Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.

Type 2 Diabetes Advisor Medication Adherence in Youth With Type 2 Diabetes: Latest Insights

Medication Adherence in Youth With Type 2 Diabetes: Latest Insights

Barriers and strategies for medication adherence in youth with type 2 diabetes were found to be similar to those observed in youth with other chronic pediatric conditions.

Practice Management What a Building Contractor Taught Me About Informed Consent

What a Building Contractor Taught Me About Informed Consent

Identifying a patient's preferences and goals leads to a care plan that can reflect those goals, and this may improve patient satisfaction.

Type 1 Diabetes Challenges of Long-Distance Air Travel With Type 1 Diabetes

Challenges of Long-Distance Air Travel With Type 1 Diabetes

Long-distance air travel presents numerous unique challenges for insulin-treated patients with diabetes. More accessible and adequate sources of guidance are needed to facilitate travel planning among this patient population.

Cardiovascular and Metabolic Disorders Metabolic Syndrome and Skin Disorders: Association Is More Than Skin Deep

Metabolic Syndrome and Skin Disorders: Association Is More Than Skin Deep

Knowing that certain characteristics increase the risk for dermatology patients who may have metabolic syndrome will enable clinicians to identify patients who may have specific cardiovascular risks.

Type 2 Diabetes Advisor Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes

Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes

Kevin Pantalone, DO, from the Cleveland Clinic, provides insight into the management of gastrointestinal symptoms in patients with diabetes.

Sign Up for Free e-Newsletters



CME Focus